Phase 3 Trial of Weekly Oral Islatravir-Lenacapavir for HIV-1 Treatment. - Rockstroh JK; Ramgopal MN; Curran Fàbregas A; Hedgcock M; Workowski KA; Ronot-Bregigeon S; Cassetti I; Brinson C; Gupta SK; Hung CC; O'Reilly M; Slim J; et al. (The New England journal of medicine, 2026)